TP53 and diabetes mellitus: During the early stage of DM (0.5 month), inhibition of p53 reduces cardiac mitochondrial cell death, whereas during late-stage DM (3–6 months), inhibition of p53 prevents DM-induced cardiac senescence and impairment of glucose metabolism and angiogenesis.